Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With T2D and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir–Ritonavir During the Omicron Wave in Hong Kong
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong
JAMA Netw Open 2023 May 01;6(5)e2314393, DTW Lui, MSH Chung, EHY Lau, KTK Lau, ICH Au, CH Lee, YC Woo, CKH Wong, BJ CowlingFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.